The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Office Visit

Office Visit

November 1, 2006 • By Lola Butcher

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Care & Clinical Trials

Cynthia Aranow, MD, has treated hundreds of patients with systemic lupus erythematosus (SLE) in the last two decades. Given the countless visits and contacts she’s had with SLE patients, she doesn’t specifically remember calling her patient Ramona* at home.

You Might Also Like
  • Office Visit
  • Office Visit
  • Office Visit
Explore This Issue
November 2006
Also By This Author
  • Go Digital

But Ramona remembers.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“There were times when I didn’t go the doctor,” she says. “And she would call me and be like, ‘You’re not coming in. You have to come in if you want me to help you and work with you.’ ”

The relationship that develops between doctor and patient can produce side effects that never get noted in a case report or published in a paper—even if the relationship has the context of a clinical trial. This is the story of one of those side effects.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Trust Built on Making Sure

Dr. Aranow is assistant professor of rheumatology at the Columbia University Medical Center in New York City—one of only nine National Institutes of Health (NIH) Autoimmune Centers of Excellence. (See “A Range of Research,” at right, for more on Dr. Aranow’s work.)

Columbia’s lupus clinic is where Ramona receives treatment. Now in her early 30s, Ramona was diagnosed with SLE when she was 14. Her disease was very active in the early years, and while aggressive treatment has made it more controllable, inflammation damaged her kidneys and she needs ongoing therapy.

A Range of Research

Dr. Aranow’s interest in basic SLE research is intensified through her clinical research and her interactions with patients like Ramona. She was lured to the research team of Betty Diamond, MD, chief of Columbia’s rheumatology division, four years ago when Dr. Diamond offered her the opportunity to add translational research to her mix of responsibilities.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Aranow’s research foci include studying the fundamental mechanisms underlying the pathogenesis of SLE, investigating why patients with SLE sometimes develop neuropsychiatric problems, and looking for new therapies for lupus.

She is currently involved in several clinical trials sponsored by both industry and the NIH, targeting diseases such as lupus, scleroderma, and rheumatoid arthritis with approaches ranging from biologics to autologous stem cell transfer.

Dr. Aranow’s other SLE research activities include:

  • Lupus Clinical Trials Consortium, a network of 23 medical centers that facilitates clinical trials.
  • Immune Tolerance Network, a collaborative that is developing therapies for immune-mediated diseases based on the induction of tolerance.
  • Systemic Lupus Erythematosus International Collaborating Clinics, an international group of researchers developing valid outcome measures for lupus.
  • Medical advisor to two chapters of the Lupus Foundation of America.—LB

The deaths of two young friends with lupus encouraged Ramona to take control of her own health, yet she did not always comply with her treatment plan. “Every time I had a different doctor,” she says. “At times, I wasn’t taking my medicine because I didn’t feel like the doctors were caring and worrying about what I was doing.”

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Patient Perspective, Profiles, SLE (Lupus) Tagged With: Care Team, Clinical research, clinical trials, Practice tools, Primary Care Physician, SLE, systemic lupus erythematousIssue: November 2006

You Might Also Like:
  • Office Visit
  • Office Visit
  • Office Visit
  • Safety First

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.